HomeNewsBusinessMarketsGlobal cotton prices likely to gain on four-year low production, higher Chinese imports

Global cotton prices likely to gain on four-year low production, higher Chinese imports

Production in China and Australia were expected to increase, while in India, the world’s largest cotton grower, the output was likely to be the same as last year at 29.5 million bales.

December 29, 2020 / 18:00 IST
Story continues below Advertisement

Global cotton prices are seen gaining this season (July 2020-June 2021) in view of production projected at a four-year low, higher imports by China and lower carry forward stocks.

According to the International Cotton Advisory Council (ICAC), global cotton production is projected at 24.7 million tonnes against earlier estimates of 24.9 million tonnes. This is against 26.2 million tonnes output last season.

Story continues below Advertisement

The US Department of Agriculture (USDA) has forecast global cotton production at 113.9 million bales of 217 kg (24.71 million tonnes) this season against 122.14 million bales (26.5 million tonnes) a year ago. This will be the lowest global cotton production since 2016-17.

Cotton production in the US, Brazil, and Pakistan are projected to be lower this year. The USDA said that Pakistan’s cotton crop is estimated at 4.5 million bales, down 27 percent over last season and its lowest in the last 36 years.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show